US2023241334A1PendingUtilityA1
In-line Nasal Delivery Device
Est. expirySep 10, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61M 15/08A61M 15/009A61M 11/02A61M 2210/0618
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A delivery device for a compound including: a housing, vial holding a compound; and a source of propellant, wherein the housing provides an inlet and an outlet for the vial, wherein the inlet is in fluid communication with the source of propellant and is directed against the compound and the outlet allows for delivery of the compound.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A device for the intranasal delivery of a compound comprising:
a y-junction including a base, a first branch of the y-junction radiating from the base, a second branch of the y-junction radiating from the base, a third branch of the y-junction radiating from the base, and an internal dose loading channel of the y-junction; a metered dose pump in fluid communication with the first branch of the y-junction; a conical spring associated with the second branch of the y-junction; a dose chamber in fluid communication with the third branch of the y-junction; a nozzle associated with the dose chamber; a diffuser between the internal dose loading channel and the dose chamber; an actuator grip surrounding the y-junction; and a housing, the y-junction residing within the housing.Join the waitlist — get patent alerts
Track US2023241334A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.